Patents by Inventor Carlos Plata

Carlos Plata has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220307628
    Abstract: A tubular irrigation device, such as a pipe or sleeve, having a circular multilayer polymeric structure including one or more layers of woven polymeric thermoplastic materials, one or more layers of thermoplastic polymeric materials, and one or more layers of polymeric waterproofing materials in film form. Methods of making the tubular irrigation device are also described.
    Type: Application
    Filed: October 1, 2020
    Publication date: September 29, 2022
    Applicant: Silverpack, LLC
    Inventor: Carlos Plata
  • Patent number: 9884881
    Abstract: The invention relates to a chelate resulting from the complexing of a trans-di-N-picolinate tetraazacycloalkane ligand with a metal cation, said ligand corresponding to formula (A) wherein n is equal to 0 or to 1, R is H or a C1-C18 alkyl radical, and R? is H or a C1-C18 alkyl radical, said metal cation being a cation of a metal selected from the group consisting of lead (II) and bismuth (III). The invention is applicable in the field of lead trapping and alpha-radioimmunotherapy.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: February 6, 2018
    Assignees: CNRS—Centre National de la Recherche Scientifique, Universite de Bretagne Occidentale
    Inventors: Raphael Tripier, Carlos Platas-Iglesias, Luis Lima, Maryline Beyler
  • Publication number: 20160115187
    Abstract: The invention relates to a chelate resulting from the complexing of a trans-di-N-picolinate tetraazacycloalkane ligand with a metal cation, said ligand corresponding to formula (A) wherein n is equal to 0 or to 1, R is H or a C1-C18 alkyl radical, and R? is H or a C1 -C18 alkyl radical, said metal cation being a cation of a metal selected from the group consisting of lead (II) and bismuth (III). The invention is applicable in the field of lead trapping and alpha-radioimmunotherapy.
    Type: Application
    Filed: June 5, 2014
    Publication date: April 28, 2016
    Inventors: RAPHAEL TRIPIER, CARLOS PLATAS-IGLESIAS, LUIS LIMA, MARYLINE BEYLER
  • Patent number: 8800536
    Abstract: Aspects of the present invention relate to systems and method for converting ozone and fuel into mechanical energy and waste products. In some embodiments, a super-combustor may be used to provide a combustion engine with an improved ability to combust fuel. Certain embodiments of the invention may provide for an improved spark plug or modified engine having a super-combustor built in.
    Type: Grant
    Filed: August 19, 2010
    Date of Patent: August 12, 2014
    Assignee: Megaion Research Corporation
    Inventor: Carlos A. Plata
  • Patent number: 8667951
    Abstract: Aspects of the present invention relate to systems and method for converting ozone and fuel into mechanical energy and waste products. In some embodiments, a super-combustor may be used to provide a combustion engine with an improved ability to combust fuel. Certain embodiments of the invention may provide for an improved spark plug or modified engine having a super-combustor built in.
    Type: Grant
    Filed: August 19, 2010
    Date of Patent: March 11, 2014
    Assignee: Megaion Research Corporation
    Inventor: Carlos A. Plata
  • Publication number: 20130324535
    Abstract: The invention refers to the use of a sigma ligand, particularly a sigma ligand of formula (I) to prevent and/or treat pain associated to bone cancer.
    Type: Application
    Filed: December 2, 2011
    Publication date: December 5, 2013
    Applicant: LABORATORIOS DEL DR. ESTEVE, S.A.
    Inventors: Daniel Zamanillo-Castanedo, José Miguel Vela-Hernández, Carlos Plata-Salaman
  • Patent number: 8501791
    Abstract: The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.
    Type: Grant
    Filed: July 13, 2010
    Date of Patent: August 6, 2013
    Assignee: Ortho-McNeil Pharamaceutical, Inc.
    Inventors: Magdalena Eisinger, Louis J. Fitzpatrick, Daniel H. Lee, Kevin Pan, Carlos Plata-Salaman, Allen B. Reitz, Virginia L. Smith-Swintosky, Boyu Zhao
  • Publication number: 20120068567
    Abstract: A motor or generator has a design that allows resistive magnetic forces that restrict the movement of the rotor to be diminished, thus increasing efficiency. A pivoting rotor design allows magnets on the rotor to break the magnetic field first in the center of the rotor due to the attraction of other magnets. The generator or motor includes a drive shaft, and at least one generator or motor stage including two stators interleaved with one rotor having a plurality of pivoting frames each including at least one magnet.
    Type: Application
    Filed: September 21, 2011
    Publication date: March 22, 2012
    Applicants: ANDEAN UNIVERSITY FUNDATION SECTIONAL PEREIRA, MEGAION RESEARCH CORPORATION
    Inventor: Carlos A. Plata
  • Publication number: 20110118957
    Abstract: Aspects of the present invention relate to systems and method for converting ozone and fuel into mechanical energy and waste products. In some embodiments, a super-combustor may be used to provide a combustion engine with an improved ability to combust fuel. Certain embodiments of the invention may provide for an improved spark plug or modified engine having a super-combustor built in.
    Type: Application
    Filed: August 19, 2010
    Publication date: May 19, 2011
    Applicant: Megaion Research Corporation
    Inventor: Carlos A. PLATA
  • Publication number: 20110108009
    Abstract: Aspects of the present invention relate to systems and method for converting ozone and fuel into mechanical energy and waste products. In some embodiments, a super-combustor may be used to provide a combustion engine with an improved ability to combust fuel. Certain embodiments of the invention may provide for an improved spark plug or modified engine having a super-combustor built in.
    Type: Application
    Filed: August 19, 2010
    Publication date: May 12, 2011
    Applicant: Megaion Research Corporation
    Inventor: Carlos A. Plata
  • Publication number: 20110056445
    Abstract: Aspects of the present invention relate to systems and method for converting ozone and fuel into mechanical energy and waste products. In some embodiments, a super-combustor may be used to provide a combustion engine with an improved ability to combust fuel. Certain embodiments of the invention may provide for an improved spark plug or modified engine having a super-combustor built in.
    Type: Application
    Filed: August 19, 2010
    Publication date: March 10, 2011
    Applicant: Megaion Research Corporation
    Inventor: Carlos A. PLATA
  • Publication number: 20100280079
    Abstract: The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.
    Type: Application
    Filed: July 13, 2010
    Publication date: November 4, 2010
    Inventors: Magdalena Eisinger, Louis J. Fitzpatrick, Daniel H. Lee, Kevin Pan, Carlos Plata-Salaman, Allen B. Reitz, Virginia L. Smith-Swintosky, Boyu Zhao
  • Patent number: 7786311
    Abstract: The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.
    Type: Grant
    Filed: August 5, 2008
    Date of Patent: August 31, 2010
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Magdalena Eisinger, Louis J. Fitzpatrick, Daniel H. Lee, Kevin Pan, Carlos Plata-Salaman, Allen B. Reitz, Virginia L. Smith-Swintosky, Boyu Zhao
  • Publication number: 20100095907
    Abstract: The invention provides for a system and method for creating an optimized fuel/air mixture for more efficient combustion. The system in accordance with the invention includes an ozone generator and a gasifier that receives liquid fuel and ozone and creates an optimized fuel of mixture. The optimized fuel/air mixture is then delivered to the cylinders of a combustion engine.
    Type: Application
    Filed: December 28, 2009
    Publication date: April 22, 2010
    Inventor: Carlos A. Plata
  • Patent number: 7637254
    Abstract: The invention provides for a system and method for creating an optimized fuel/air mixture for more efficient combustion. The system in accordance with the invention includes an ozone generator and a gasifier that receives liquid fuel and ozone and creates an optimized fuel of mixture. The optimized fuel/air mixture is then delivered to the cylinders of a combustion engine.
    Type: Grant
    Filed: April 18, 2007
    Date of Patent: December 29, 2009
    Assignee: Megaion Research Corporation
    Inventor: Carlos A. Plata
  • Publication number: 20090203751
    Abstract: The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.
    Type: Application
    Filed: August 5, 2008
    Publication date: August 13, 2009
    Inventors: Magdalena Eisinger Eisinger, Louis J. Fitzpatrick, Daniel H. Lee, Kevin Pan, Carlos Plata-Salaman, Allen B. Reitz, Virginia L. Smith-Swintosky, Boyu Zhao
  • Publication number: 20090170759
    Abstract: Methods of treating diseases of the nervous system by administration of compositions having the neurological therapeutic activity of human erythropoietin are disclosed. These compositions include therapeutic agents such as peptides, peptide dimers, polypeptides, and proteins that have the full range of biological activity of human erythropoietin or only certain biological activities of erythropoietin. Improved therapeutic regimens where the erythropoietin is administered at concentrations below those required to stimulate hematopoiesis are also provided.
    Type: Application
    Filed: July 11, 2007
    Publication date: July 2, 2009
    Inventors: Virginia Smith-Swintosky, Michael Renzi, Carlos Plata-Salaman, Linda Jolliffe, Francis Farrell, Dana Johnson
  • Patent number: 7375123
    Abstract: The present invention is directed to novel 1,2,4-thiadiazole derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.
    Type: Grant
    Filed: February 1, 2006
    Date of Patent: May 20, 2008
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Magdalena Eisinger, Louis J. Fitzpatrick, Daniel H. Lee, Kevin Pan, Carlos Plata-Salaman, Allen B. Reitz, Virginia L. Smith-Swintosky, Boyu Zhao
  • Publication number: 20080072882
    Abstract: The invention provides for a system and method for creating an optimized fuel/air mixture for more efficient combustion. The system in accordance with the invention includes an ozone generator and a gasifier that receives liquid fuel and ozone and creates an optimized fuel of mixture. The optimized fuel/air mixture is then delivered to the cylinders of a combustion engine.
    Type: Application
    Filed: April 18, 2007
    Publication date: March 27, 2008
    Inventor: Carlos Plata
  • Patent number: 7319107
    Abstract: The present invention is directed to novel 1,2,4-thiadiazol-2-ium derivatives useful as agonists or antagonists of the melanocortin receptor. More particularly, the compounds of the present invention are useful for the treatment of metabolic, CNS and dermatological disorders such as obesity, impaired oral glucose tolerance, elevated blood glucose levels, type II diabetes, Syndrome X, diabetic retinopathy, spinal cord injury, nerve injury, acute neurodegenerative disorders, chronic neurodegenerative disorders, plexopathies, male erectile dysfunction, dry eyes, acne, dry skin, aged skin, seborrheic dermatitis, rosacea, excessive ear wax, meibomian gland disorder, pseudofolliculitis, yeast infections, dandruff, hidradenitis suppurativa, ocular rosacea and eccrine gland disorder.
    Type: Grant
    Filed: November 4, 2002
    Date of Patent: January 15, 2008
    Assignee: Johnson & Johnson Consumer Companies, Inc.
    Inventors: Magdalena Eisinger, Louis J. Fitzpatrick, Daniel H. Lee, Kevin Pan, Carlos Plata-Salaman, Allen B. Reitz, Virginia L. Smith-Swintosky, Boyu Zhao